IL-1RL1

IL-1RL1 詳細

英語名Interleukin-1 receptor-like 1市販薬剤の数0
治験薬の数5ターゲットの別称ST2,IL1RL1,Protein ST2,DER4,T1,Interleukin 1 Receptor Like 1,Homolog Of Mouse Growth Stimulation-Expressed,Interleukin 1 Receptor-Related Protein,Growth Stimulation-Expressed,FIT-1,IL33R,ST2L,ST2V,Interleukin-1 Receptor-Like 1 Protein,EC:3.2.2.6,Interleukin-1 Receptor-Like 1
研究&開発段階NDA/BLA
英語名Interleukin-1 receptor-like 1
ターゲットの別称ST2,IL1RL1,Protein ST2,DER4,T1,Interleukin 1 Receptor Like 1,Homolog Of Mouse Growth Stimulation-Expressed,Interleukin 1 Receptor-Related Protein,Growth Stimulation-Expressed,FIT-1,IL33R,ST2L,ST2V,Interleukin-1 Receptor-Like 1 Protein,EC:3.2.2.6,Interleukin-1 Receptor-Like 1
市販薬剤の数0
治験薬の数5
研究&開発段階NDA/BLA

IL-1RL1 製品リスト

  • 属性

    Protein (5)

  • 製品ライブラリ

    オンライン (5)

  • Human (4)Mouse (1)

  • タグ

    His Tag (1)Fc Tag (2)His Tag & Avi Tag (1)Fc Tag & Avi Tag (1)

  • マーカー

    Unconjugated (3)Biotin-labeled (2)

IL-1RL1バックグランド

Interleukin 1 receptor-like 1 (IL1RL1) is also known as ST2, DER4, FIT-1, IL33R, ST2L, ST2V, which belongs to the interleukin-1 receptor family. IL1RL1 contains three Ig-like C2-type (immunoglobulin-like) domains and one TIR domain. IL1RL1 is receptor for interleukin-33 (IL-33), its stimulation recruits MYD88, IRAK1, IRAK4, and TRAF6, followed by phosphorylation of MAPK3/ERK1 and/or MAPK1/ERK2, MAPK14, and MAPK8. IL1RL1 possibly involved in helper T-cell function. IL1RL1 can interact with MYD88, IRAK1, IRAK4, and TRAF6.

IL-1RL1分子の別称

IL1RL1,DER4,FIT-1,IL33R,ST2,ST2L,ST2V,T1

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
AstegolimabAMG-282; RG-6149; RO-7187807Phase 3 ClinicalAmgen Inc, F. Hoffmann-La Roche LtdCoronavirus Disease 2019 (COVID-19); Dermatitis, Atopic; Pulmonary Disease, Chronic Obstructive
詳細
AK-139AK139; AK-139Phase 2 ClinicalKangfang Biotechnology (Cayman) Co LtdAsthma; Chronic rhinosinusitis with nasal polyps (CRSwNP); Chronic Urticaria; Dermatitis, Atopic; Hypersensitivity; Prurigo Nodularis; Pulmonary Disease, Chronic Obstructive; Rhinitis, Allergic; Rhinitis, Allergic, Seasonal
詳細
TQC-2938TQC2938; TQC-2938Phase 2 ClinicalNanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical GroupAsthma; Pulmonary Disease, Chronic Obstructive; Rhinitis, Allergic, Seasonal
詳細
Recombinant humanized anti-ST2 monoclonal antibody9-MW1911; 9MW-1911; 9-MW-1911; 9MW1911Phase 2 ClinicalMabwell (Shanghai) Bioscience Co LtdAsthma; Dermatitis, Atopic; Pulmonary Disease, Chronic Obstructive
詳細
NEROFEPhase 1 ClinicalImmune System Key LtdNeoplasms; Solid tumours
詳細
  • 詳細
  • 製品リスト
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8